Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03889899 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 2, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Jun 2025 to Jun 2026v10
  2. Primary completion date: Jun 2024 to Jun 2025
    • Study completion date: Sep 2024 to Sep 2026
    v9
  3. 2 versions Re-verified since Jun 14, 2022, no change to tracked fieldsv7-v8
  4. Primary completion date: Jun 2022 to Jun 2024
    • Study completion date: Sep 2022 to Sep 2024
    v6
  5. Start date changed from estimate of Jul 2020 to Oct 21, 2020v5
Show 3 earlier versionsHide 3 earlier versions
  1. Trial status: Not Yet Recruiting to Recruitingv4 Show 4 more changesShow less
    • Start date: Jan 2020 to Jul 2020
    • Primary completion date: Jan 2022 to Jun 2022
    • Study completion date: Jan 2022 to Sep 2022
    • Site details revised
  2. Primary completion date: Jun 2021 to Jan 2022
    • Start date: Jun 2019 to Jan 2020
    • Study completion date: Sep 2021 to Jan 2022
    v3
  3. Secondary endpoints: details revised at 2 of 4 entriesv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for superficial cutaneous, mucosal or soft tissue neoplasia
Trial Details
NCT Number NCT03889899
Lead Sponsor Alpha Tau Medical LTD.
Conditions
(from sponsor)		 Skin Cancer, Mucosal Neoplasm of Oral Cavity, Soft Tissue Neoplasm
Related terms Basal Cell Carcinoma, Carcinoma, Squamous Cell, Lip Neoplasms, Sarcoma, Kaposi, Skin Neoplasms, Soft Tissue Neoplasms, Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov